CATALAYER NEWS
FDA approves LivaNova’s device combo to treat drug-resistant epilepsy - Fierce Biotech
Source: Fierce Biotech · 2017-10-09
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
RELATED MARKETS
Prediction Markets